BI BIOMERICA INC Stock: price and insider trades · United States · SEC (Form 4)Track the BIOMERICA INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €4.6m. The latest transaction was filed on 27 August 2026 (Acquisition). Among the most active insiders: Irani Zackary S.. The full history is openly available.
€171,108
16 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,991 of 29,063 companies
FCF yld -59%
Earn yld -75%
EV/EBITDA ·
ROE -94%
Gross mgn 9.4%
Net mgn -94%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 August 2026
All Executives28 Thresholds0 Prospectus0 Other0
Declarations 28 total
▲ Executive Vice Chairman · Executives · 26 Aug 2026
20,000 shares @ US$1.60 Common stock SEC:0001493152-26-040444:0
Canonical exit: 24 Nov 2026 (T+90) ▲ Chief Executive Officer · Executives · 26 Aug 2026
31,250 shares @ US$1.60 Common stock SEC:0001493152-26-040443:0
Canonical exit: 24 Nov 2026 (T+90) ▲ Director · Executives · 26 Aug 2026
6,250 shares @ US$1.60 Common stock SEC:0001493152-26-040448:0
Canonical exit: 24 Nov 2026 (T+90) ▲ Director · Executives · 26 Aug 2026
10,000 shares @ US$1.60 Common stock SEC:0001493152-26-040450:0
Canonical exit: 24 Nov 2026 (T+90) ▲ Director · Executives · 20 Aug 2026
31,250 shares @ US$1.60 Common stock SEC:0001493152-26-040454:0
Canonical exit: 18 Nov 2026 (T+90) ◆ Director · Executives · 12 Dec 2025
22,500 shares 0Common stock SEC:0001493152-26-004083:0
◆ Chief Financial Officer · Executives · 12 Dec 2025
40,000 shares 0Common stock SEC:0001493152-25-029843:0
◆ Chief Executive Officer · Executives · 12 Dec 2025
52,500 shares 0Common stock SEC:0001493152-25-029842:0
◆ Executive Vice-Chairman · Executives · 12 Dec 2025
30,000 shares 0Common stock SEC:0001493152-25-029841:0
◆ Director · Executives · 12 Dec 2025
20,000 shares 0Common stock SEC:0001493152-25-029840:0
◆ Director · Executives · 12 Dec 2025
20,000 shares 0Common stock SEC:0001493152-25-029839:0
◆ Chief Financial Officer · Executives · 13 Dec 2024
155,000 shares @ US$0.31 100.0% of flow Common stock SEC:0001493152-24-050503:0
◆ Director · Executives · 13 Dec 2024
85,000 shares @ US$0.31 100.0% of flow Common stock SEC:0001493152-24-050502:0
◆ Director · Executives · 13 Dec 2024
85,000 shares @ US$0.31 80.9% of flow Common stock SEC:0001493152-24-050500:0
◆ Executive Vice Chairman · Executives · 13 Dec 2024
110,000 shares @ US$0.31 88.7% of flow Common stock SEC:0001493152-24-050499:0
◆ Chief Executive Officer · Executives · 13 Dec 2024
250,000 shares @ US$0.31 74.2% of flow Common stock SEC:0001493152-24-050501:0
◆ Director · Executives · 13 Dec 2024
85,000 shares @ US$0.31 100.0% of flow Common stock SEC:0001493152-24-050504:0
▲ Chief Executive Officer · Executives · 24 May 2023
500 shares @ US$1.61 0.8% of flow Common Stock SEC:0001513162-23-000101:0
Canonical exit: 22 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 12 May 2023
1,700 shares @ US$1.17 1.8% of flow Common Stock SEC:0001513162-23-000092:0
Canonical exit: 10 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 10 May 2023
500 shares @ US$1.27 0.6% of flow Common Stock SEC:0001513162-23-000091:0
Canonical exit: 8 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 9 May 2023
300 shares @ US$1.39 0.4% of flow Common Stock SEC:0001513162-23-000088:0
Canonical exit: 7 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 4 May 2023
1,000 shares @ US$1.36 1.2% of flow Common Stock SEC:0001513162-23-000082:0
Canonical exit: 2 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 27 Apr 2023
2,600 shares @ US$1.31 3.1% of flow Common Stock SEC:0001513162-23-000078:0
Canonical exit: 26 Jul 2023 (T+90) ▲ Chief Executive Officer · Executives · 26 Apr 2023
7,000 shares @ US$1.26 8.0% of flow Common Stock SEC:0001513162-23-000077:0
Canonical exit: 25 Jul 2023 (T+90) ▲ Executive Vice Chairman · Executives · 27 Jan 2023
1,538 shares @ US$2.94 11.3% of flow Common Stock SEC:0001513162-23-000011:0
Canonical exit: 27 Apr 2023 (T+90) 25 of 28 declarations
Load more (3 remaining) 关于 BIOMERICA INC BIOMERICA INC是一家专注于人类健康诊断测试开发和制造的公司。它主要在美国市场运营。